Skip to main content
All lobbying filings

MCDERMOTT WILL & SCHULTE LLP

Lobbying for SURESCRIPTS · Health IT Company

 Filing 2nd Quarter - Report
2nd Quarter (Apr 1 - June 30) 2026 · Virginia · House · Senate · $30,000.00 income · posted Jul 9, 2026

Official filing document

 Bills named in this filing 2
  • HR 3164
    Ensuring Community Access to Pharmacist Services Act
  • S 2426
    Equitable Community Access to Pharmacist Services Act
 Lobbying activity 3
Health Issues

Efforts to promote interoperability, advance electronic prescribing of controlled substances, and ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to improve access to pharmacist services, including H.R. 3164 and S. 2426, the Main Street Pharmacy Access Act/the Equitable Community Access to Pharmacist Services Act.

Science/Technology

Efforts to advance interoperability and to ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to improve access to pharmacist services, including H.R. 3164 and S. 2426, the Main Street Pharmacy Access Act/the Equitable Community Access to Pharmacist Services Act.

Medicare/Medicaid

Efforts to promote interoperability, advance electronic prescribing of controlled substances, and ensure that technological advances in the pharmacy services sector, including in electronic prescribing and electronic prior authorization, benefit patients, prescribers, and others in a timely way. Efforts to promote access to pharmacist services, including H.R. 3164 and S. 2426, the Main Street Pharmacy Access Act/the Equitable Community Access to Pharmacist Services Act.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem